Choose a Section
Most recent by Seth J. Baum, MD
SPONSORED CONTENT
May 18, 2023
4 min read
Save
Lipoprotein(a): The next frontier in CV risk reduction
This installment of Pipeline Pulse focuses on a single cardiovascular risk factor, lipoprotein(a), and examines two CV outcomes trials aimed at reducing CV events through Lp(a) reduction.
SPONSORED CONTENT
December 19, 2022
5 min read
Save
Pipeline Pulse: A look at tirzepatide, ziltivekimab and obicetrapib
The field of cardiology has seen stunning advances in the past several years: HF, dyslipidemia and cardiomyopathy are just three of the disorders in which there have been recent practice-changing therapeutic innovations.